ABLSA, AmeriPath Settle Diagnostic Patent Spat

Law360, New York (June 27, 2008, 12:00 AM EDT) -- An international patent dispute was resolved Thursday, as biotechnology company Advanced Biological Laboratories SA and diagnostic company AmeriPath Inc. settled an infringement suit over HIV treatment selection patents.

Luxembourg-based ABLSA and AmeriPath agreed to bury the hatchet, withdrawing all claims and counterclaims in the suit filed in the U.S. District Court for the Eastern District of Texas.

Judge Leonard Davis approved the confidential settlement Thursday, dismissing the suit with prejudice and allowing each party to pay its litigation expenses.

The settlement, however, allows for possible future...
To view the full article, register now.